Gastroesophageal Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

695 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 228
Recruiting: 123
Ph III recruiting: 18
Growth YoY: +39.5%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (82)

clinicaltrialsPublishedShowing 151–152 of 152 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05291728	Screening for Early Gastric Cancer in Shaanxi Province	recruiting	—	12,500,000	Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER	1	Mar 23, 2022	clinicaltrials
NCT04018872	Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer	recruiting	Phase 2	78	Dallas VA Medical CenterFED	1	Nov 4, 2021	clinicaltrials